scholarly article | Q13442814 |
P50 | author | Myron S. Cohen | Q16733099 |
William C. Miller | Q30507980 | ||
Jane R Schwebke | Q97118155 | ||
Julius Atashili | Q115147099 | ||
Peter A. Leone | Q121075428 | ||
Heidi Swygard | Q125217147 | ||
P2093 | author name string | Marcia M Hobbs | |
Arlene C Seña | |||
P2860 | cites work | Trichomoniasis in men and HIV infection: data from 2 outpatient clinics at Lilongwe Central Hospital, Malawi | Q30960781 |
The infrequent use of office-based diagnostic tests for vaginitis | Q33690613 | ||
Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens | Q33824751 | ||
Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women | Q33947022 | ||
Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens | Q33973382 | ||
Improved detection by DNA amplification of Trichomonas vaginalis in males | Q34200955 | ||
Trichomoniasis: under control or undercontrolled? | Q34293435 | ||
Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men. | Q34748499 | ||
Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis | Q35220782 | ||
Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions | Q35528767 | ||
Laboratory tests used in US public health laboratories for sexually transmitted diseases, 2000. | Q35755519 | ||
The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment | Q36955440 | ||
High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management | Q37868981 | ||
Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus | Q37872788 | ||
Predictors of the vaginal microflora | Q37874418 | ||
Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic | Q37876647 | ||
Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis | Q37879288 | ||
Rates of and risk factors for trichomoniasis among pregnant inmates in New York City | Q37880630 | ||
Risk assessment and laboratory diagnosis of trichomoniasis in men. | Q37892133 | ||
Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. | Q38570406 | ||
Genital Ulcers Associated with Human Immunodeficiency Virus-Related Immunosuppression in Female Sex Workers in Abidjan, Ivory Coast | Q45788322 | ||
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group | Q47305969 | ||
The prevalence of trichomoniasis in young adults in the United States. | Q54638256 | ||
Trichomonas vaginalis--no longer a minor STD. | Q55033250 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sexually transmitted infection | Q12198 |
Trichomonas vaginalis | Q132595 | ||
prevention | Q1717246 | ||
P304 | page(s) | 13-22 | |
P577 | publication date | 2006-11-27 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. | |
P478 | volume | 44 |
Q36311615 | A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections |
Q98166342 | A Systematic Review of the Literature on Mechanisms of 5-Nitroimidazole Resistance in Trichomonas vaginalis |
Q37641408 | Can trichomoniasis cause pharyngitis? A case report. |
Q49579805 | Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (abridged version). |
Q49579785 | Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version). |
Q26778560 | Clinical and Laboratory Testing for Trichomonas vaginalis Infection |
Q36871544 | Comparative analysis of syndromic and PCR-based diagnostic assay reveals misdiagnosis/ overtreatment for trichomoniasis based on subjective judgment in symptomatic patients |
Q64101932 | Comparison of Seropositivity to Trichomonas vaginalis between Men with Prostatic Tumor and Normal Men |
Q40304979 | Correlates of Trichomonas vaginalis Among Middle Age and Older Adults Who Use Drugs. |
Q37855843 | Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica. |
Q37050952 | Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans |
Q42252382 | Current status and prospects for development of a vaccine against Trichomonas vaginalis infections |
Q36142110 | Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia. |
Q58835870 | Diagnosing Vaginal Infections: It’s Time to Join the 21st Century |
Q37374876 | Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women |
Q58835994 | Editorial Commentary: Trichomonas vaginalisInfection: The Most Prevalent Nonviral Sexually Transmitted Infection Receives the Least Public Health Attention |
Q37270533 | Epidemiology and treatment of trichomoniasis |
Q35880422 | Genital infections and syndromic diagnosis among HIV-infected women in HIV care programmes in Kenya |
Q37497330 | Ginger (Zingiber officinale) induces apoptosis in Trichomonas vaginalis in vitro |
Q38112673 | Global epidemiology of Trichomonas vaginalis |
Q42740170 | Gonorrhoea & its co-infection with other ulcerative, non-ulcerative sexually transmitted & HIV infection in a Regional STD Centre |
Q38247206 | Immunity in urogenital protozoa |
Q37456846 | Impact of T. vaginalis infection on innate immune responses and reproductive outcome |
Q36911891 | Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis |
Q38797613 | Inflammatory response of a prostate stromal cell line induced by Trichomonas vaginalis |
Q39043131 | Inflammatory response of prostate epithelial cells to stimulation by Trichomonas vaginalis |
Q38128845 | Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community |
Q33745589 | Interaction between Trichomonas vaginalis and the Prostate Epithelium. |
Q35276050 | Internet-based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men |
Q36105015 | Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis |
Q37119274 | Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention |
Q35220782 | Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis |
Q36180027 | Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care |
Q26822739 | Modern diagnosis of Trichomonas vaginalis infection |
Q38382893 | Natural and synthetic compound anti-Trichomonas vaginalis: an update review |
Q33588454 | Neglected parasitic infections in the United States: trichomoniasis |
Q30239882 | Nonviral sexually transmitted infections-epidemiology, clinical manifestations, diagnostic workup, therapy : Part 3: Treponemes, Gardnerella and trichomonads |
Q36032897 | PCR for diagnosis of male Trichomonas vaginalis infection with chronic prostatitis and urethritis |
Q37550276 | Prevalence and Correlates of Genital Infections Among Newly Diagnosed Human Immunodeficiency Virus-Infected Adults Entering Human Immunodeficiency Virus Care in Windhoek, Namibia |
Q40068325 | Prevalence of Mycoplasma genitalium and other sexually transmitted infections causing urethritis among high-risk heterosexual male patients in Estonia |
Q34411072 | Prevalence of Trichomonas vaginalis by PCR in men attending a primary care urology clinic in South Korea |
Q41921303 | Prevalence of Trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study |
Q34019287 | Prevalence of Trichomonas vaginalis infection in Kashan city, Iran (2012-2013) |
Q36911870 | Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea |
Q36880250 | Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men. |
Q90235676 | Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana |
Q37834503 | Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals |
Q39136758 | Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell |
Q24650442 | Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study |
Q90470116 | Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection |
Q84952075 | Refractory Trichomoniasis in HIV-positive and HIV-negative Subjects |
Q33696455 | Regulation of gene expression in protozoa parasites |
Q55717765 | Review of Trichomonas vaginalis in Iran, Based on Epidemiological Situation. |
Q34479272 | Sexually transmitted diseases treatment guidelines, 2015. |
Q36998820 | Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Q38736205 | Signalling pathways associated with IL-6 production and epithelial-mesenchymal transition induction in prostate epithelial cells stimulated with Trichomonas vaginalis |
Q50028228 | Susceptibility of clinical isolates of Trichomonas vaginalis to metronidazole and secnidazole-an in vitro study |
Q37214609 | The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis |
Q35836824 | The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya |
Q37456656 | The male sexual partners of adult versus teen women with sexually transmitted infections |
Q51109089 | The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. |
Q48613148 | Therapeutic effects of Iranian herbal extracts against Trichomonas vaginalis |
Q55473211 | Therapeutic effects of Iranian herbal extracts against Trichomonas vaginalis. |
Q55363854 | Trichomonas vaginalis Induces Production of Proinflammatory Cytokines in Mouse Macrophages Through Activation of MAPK and NF-κB Pathways Partially Mediated by TLR2. |
Q36826973 | Trichomonas vaginalis contact-dependent cytolysis of epithelial cells |
Q90639070 | Trichomonas vaginalis extracellular vesicles are internalized by host cells using proteoglycans and caveolin-dependent endocytosis |
Q36368342 | Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence |
Q30358403 | Trichomonas vaginalis screening and prevention in order to impact the HIV pandemic: Isn't it time we take this infection seriously? |
Q27025282 | Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues |
Q38627476 | Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure |
Q34173528 | Trichomoniasis: evaluation to execution |
Q34387759 | Trichomoniasis: the "neglected" sexually transmitted disease |
Search more.